06 Oct 2025 | 3 Mins Read
Zydus Lifesciences receives USFDA approval for deflazacort suspension
Flipitmoney
Zydus Lifesciences Ltd. received final USFDA approval for deflazacort oral suspension, a generic version of Emflaza. Indicated for treating Duchenne Muscular Dystrophy, the product will be manufactured in Italy. This is Zydus' 424th US Approval. The company has filed 487 ANDAs, with one pending NDA.